Global

Global

The latest news from the global pharmaceutical industry

First Indian Intranasal COVID-19 Vaccine Recently LaunchedFirst Indian Intranasal COVID-19 Vaccine Recently Launched
First Indian Intranasal COVID-19 Vaccine Recently Launched

Bharat Biotech has recently launched its new intranasal COVID-19 vaccine iNCOVACC

Mar 6, 2023 Global
Australia’s TGA Approves Psychedelics To Treat Mental Health ConditionsAustralia’s TGA Approves Psychedelics To Treat Mental Health Conditions
Australia’s TGA Approves Psychedelics To Treat Mental Health Conditions

The TGA has announced its approval of the use of psychedelics to treat certain mental health conditions

Mar 6, 2023 Global
Drug-resistant Bacterium Found In Eye Drops Has Infected 55 People In 12 StatesDrug-resistant Bacterium Found In Eye Drops Has Infected 55 People In 12 States
Drug-resistant Bacterium Found In Eye Drops Has Infected 55 People In 12 States

A strongly drug-resistant bacterium has been found in various brands of artificial tears eye drops, infecting 55 people throughout 12 states

Mar 6, 2023 Global
Johnson & Johnson Subsidiary Loses US Bankruptcy BidJohnson & Johnson Subsidiary Loses US Bankruptcy Bid
Johnson & Johnson Subsidiary Loses US Bankruptcy Bid

A subsidiary of J&J has lost a bankruptcy petition aiming to transfer thousands of legal claims against the subsidiary related to the claim that its talcum powder causes cancer

Mar 6, 2023 Global
WHO Issues A ‘Call To Action’ After Cough Syrup DeathsWHO Issues A ‘Call To Action’ After Cough Syrup Deaths
WHO Issues A ‘Call To Action’ After Cough Syrup Deaths

WHO has issued a 'call to action' to all member states in order to try to prevent, detect and respond to incidences of illegitimate medical products

Mar 6, 2023 Global
Stand Up To Cancer Announces Four Teams Dedicated To Increasing Diversity In Clinical TrialsStand Up To Cancer Announces Four Teams Dedicated To Increasing Diversity In Clinical Trials
Stand Up To Cancer Announces Four Teams Dedicated To Increasing Diversity In Clinical Trials

SU2C has announced four teams focusing on increasing diversity in early phase cancer clinical trials

Mar 6, 2023 Global
Gambian Panel Recommends Maiden Pharmaceuticals Be Held Culpable For Cough SyrupGambian Panel Recommends Maiden Pharmaceuticals Be Held Culpable For Cough Syrup
Gambian Panel Recommends Maiden Pharmaceuticals Be Held Culpable For Cough Syrup

A parliamentary committee in the Gambia has recommended prosecution of the Indian pharma manufacturer Maiden Pharmaceuticals, as it has sold contaminated medicine that is believed to be linked to the deaths of at least 70 children in the Gambia.

Feb 1, 2023 Global
Fda Approves First Gene Therapy To Treat Patients With High-risk, Non-muscle-invasive Bladder CancerFda Approves First Gene Therapy To Treat Patients With High-risk, Non-muscle-invasive Bladder Cancer
Fda Approves First Gene Therapy To Treat Patients With High-risk, Non-muscle-invasive Bladder Cancer

The FDA has approved Adstiladrin (scientific name nadofaragene firadenovec-vncg) for the treatment of adult patients with high-risk Bacillus Calmette-Guérin (BCG)- unresponsive non-muscle-invasive bladder cancer (NMIBC) with carcinoma in situ (CIS) with or without papillary tumours.

Feb 1, 2023 Global
Two Biotech Ceos Charged With Defrauding Investors Over Investigational HIV DrugTwo Biotech Ceos Charged With Defrauding Investors Over Investigational HIV Drug
Two Biotech Ceos Charged With Defrauding Investors Over Investigational HIV Drug

Two US biotech CEOs have been highlighted for their roles in a conspiracy to defraud investors in CytoDyn, a company developing an investigational drug to treat human immunodeficiency virus (HIV).

Feb 1, 2023 Global
Fda Expands Access To Abortion PillsFda Expands Access To Abortion Pills
Fda Expands Access To Abortion Pills

Following new rules from the FDA under the Biden administration, patients can now obtain the abortion pill mifepristone from retail pharmacies, rather than having to collect the medication in person from their healthcare provider. A prescription for the drug is still required, however this can now be filled at an instore pharmacy or by mail order.

Feb 1, 2023 Global
Fda Approves Eisai-biogen’s Lecanemab For Alzheimer’s DiseaseFda Approves Eisai-biogen’s Lecanemab For Alzheimer’s Disease
Fda Approves Eisai-biogen’s Lecanemab For Alzheimer’s Disease

The FDA has approved new and contraversial Alzheimer’s drug, lecanemab

Feb 1, 2023 Global
Tamiflu Manufacturers Report Shortages During High Point Of Flu SeasonTamiflu Manufacturers Report Shortages During High Point Of Flu Season
Tamiflu Manufacturers Report Shortages During High Point Of Flu Season

The CDC has reported at least 23,000 hospitalisations due to influenza while this year’s flu season is at a high point, which has led to multiple manufacturers reporting shortages of a flu drug, Tamiflu.

Feb 1, 2023 Global